David G Mann
Biographic Data
| ID | 9596271 |
|---|---|
| NAME | David G Mann |
| GIVEN NAMES | David G |
| FAMILY NAME | Mann |
| SIGNATURE | MANN D G |
| AFFILIATIONS | Baylor College of Medicine |
| ORCID | 0000-0003-0522-6802 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1997 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Harm reduction in paediatric off-label therapy
Cystic fibrosis (CF) is a life-limiting genetic disease frequently associated with pancreatic insufficiency (PI), traditionally considered irreversible. CF transmembrane conductance regulator modulators such as elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta) have transformed CF care yet remain FDA-approved only for children aged 2 years and older. We present the case of a 9-month-old female with CF and PI whose mother, highly health-literate and…
Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia
Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia. D MannCopyRight https://doi.org/10.2105/AJPH.87.4.692 Published Online: October 07, 2011
No prominent works on this page.
Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia
Integrating HIV prevention, STD, and family planning services. Comprehensive efforts in Philadelphia. D MannCopyRight https://doi.org/10.2105/AJPH.87.4.692 Published Online: October 07, 2011
Harm reduction in paediatric off-label therapy
Cystic fibrosis (CF) is a life-limiting genetic disease frequently associated with pancreatic insufficiency (PI), traditionally considered irreversible. CF transmembrane conductance regulator modulators such as elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta) have transformed CF care yet remain FDA-approved only for children aged 2 years and older. We present the case of a 9-month-old female with CF and PI whose mother, highly health-literate and…
Adolescent Sexual and Reproductive Health (1 work) · Best interests (1 work) · Cystic fibrosis (1 work) · Cystic Fibrosis Research Advances (1 work) · Cystic fibrosis transmembrane conductance regulator (1 work) · Disease (1 work) · Do no harm (1 work) · Environmental health (1 work) · Ethics and Legal Issues in Pediatric Healthcare (1 work) · Family medicine (1 work)